What is TB-500 / thymosin beta-4?
TB-500 is a marketing and research label that is often linked to thymosin beta-4. The exact sequence matters: full-length thymosin beta-4 and a fragment are not interchangeable research materials. A name on a vial is insufficient to determine which molecule a study investigated.
What the science shows
A randomized phase 2 trial studied thymosin beta-4 eye drops for severe dry eye. That is a specific ophthalmic formulation and indication. It does not demonstrate that an injectable product sold as TB-500 repairs a tendon or improves athletic recovery.
Potential advantages and evidence limits
Thymosin-related biology creates legitimate research questions around tissue responses. The practical advantage claimed in sports and recovery marketing requires direct human evidence for the same sequence and route. Evidence cannot be transferred solely because two names are associated online.
Risks, side effects and uncertainty
Human safety data for one preparation do not establish the safety profile of every fragment, blend or route. Long-term and systemic effects require their own investigation. Supplier reports should identify the actual sequence and mass rather than relying only on the label TB-500.
What people report experiencing
Recovery stories commonly involve several simultaneous changes. Training load, rest, rehabilitation and symptom fluctuation all need consideration. We have not assembled a verified, representative dataset of TB-500 user outcomes, so no frequency or typical benefit is claimed here.
How to evaluate a claim
Ask whether the cited paper studied the exact peptide, formulation and outcome being advertised. Start with the original publication below. Check the participants, comparator, formulation, outcome and follow-up. Separate what the authors measured from what a seller or social post says the finding means. A result can be statistically significant while its practical importance remains limited.
Product quality is a separate question
Clinical evidence concerns a defined intervention. Supplier evidence concerns a defined sample. Neither replaces the other. A purity percentage is not a clinical endorsement; an interesting study does not authenticate a product. Use the supplier reviews below to examine documentation, then read the methodology to understand what a documentary score can and cannot establish.
Frequently asked questions
Does TB-500 / thymosin beta-4 have proven benefits?
Thymosin-related biology creates legitimate research questions around tissue responses. The practical advantage claimed in sports and recovery marketing requires direct human evidence for the same sequence and route. Evidence cannot be transferred solely because two names are associated online.
Are user experiences reliable evidence?
Recovery stories commonly involve several simultaneous changes. Training load, rest, rehabilitation and symptom fluctuation all need consideration. We have not assembled a verified, representative dataset of TB-500 user outcomes, so no frequency or typical benefit is claimed here.
Does a high-purity certificate prove safety?
No. A sample certificate and clinical safety answer different questions. Identity, quantity, contaminants, formulation and clinical evidence must be assessed separately.
Check the population, product, route, comparator and outcome. A laboratory mechanism is not a proven health benefit, and a supplier’s certificate is not a clinical study.
Follow the evidence
Sources accessed 10 September 2026. Vendor claims and vendor-hosted reports are identified as such.